SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification from Parabolic Drugs

06 Apr 2015 Evaluate

With reference to the Increase in price, Parabolic Drugs has Clarified as on date, there exists no information as is required to be furnished to the Stock Exchange in terms of Clause 36 of the Listing Agreement.

The above information is a part of company’s filings submitted to BSE.

 

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.45
Dr. Reddys Lab 1219.20
Cipla 1229.70
Zydus Lifesciences 939.65
Lupin 2317.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×